Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Dec 27, 2020 9:52pm
132 Views
Post# 32186261

RE:PMX for Covid-19 Dec 15 published Study

RE:PMX for Covid-19 Dec 15 published Study

mercedesman wrote: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21861



Key snipits - Discussion



PMX itself is used in the treatment of endotoxemia and septic shock caused bygram-negative rods. However, it is also expected to adsorb endogenous substances and cytokines

As shown in Figure 3,IL-6 levels showed an overall downward trend. 



Results

On day 14 after the first treatment, disease severity decreased in 58.3% of the patients.



Conclusion



PMX-DHP may have a beneficial effect on patients with COVID-19. Therefore, future prospective studies with acontrol group are expected to evaluate the therapeuticeffect of PMX-DHP in patients with COVID-19. 



I gather endedupHyonPot was lonely over the holidays and ended up taking some cheap shots. 


thought I would re-post the above Study on Covid and PMX ...even tho no one offered an opinion.  Although oddly the personal attacks seemed to increase after I posted it. 


Seems the good Doctor has a view point that is contrary to some slowly mounting evidence. Anyone have any thoughts as to why? 

See also Vincenza videos. 

See also World Sepsis Alliance statement. 


let's see who is capable of staying on topic? And maybe that will reveal something about those that cannot .


MM 
 

<< Previous
Bullboard Posts
Next >>